| HOME >> BIOLOGY >> TECHNOLOGY |
Long-term debt $38,465 $38,443 $277
Stockholders' equity $428,091 $397,266 $316,616
(a) Fiscal Year 2007 numbers have been adjusted to reflect Fiscal Year
2008 presentation. Certain direct costs have been moved to selling,
general and administrative to ensure consistency among all business
segments.
(b) Represents an $11.1 million reversal of certain U.S. tax valuation
reserves, which were offset by $2.4 million in adjustments to the
Netherlands tax reserves.
PAREXEL International Corporation
Consolidated Condensed Statement of Income
(In thousands, except per share data)
Unaudited
Twelve Months Ended
June 30, 2008 June 30, 2007
As As
Reported Adjustments Adjusted Reported(a)
Service revenue $964,283 $964,283 $741,955
Reimbursement revenue 198,687 198,687 176,149
Total revenue 1,162,970 1,162,970 918,104
Costs and expenses:
Direct costs 629,399 629,399 483,887
Reimbursable out-of-
pocket expenses 198,687 198,687 176,149
Selling, general and
administrative 211,392 211,392 169,681
Depreciation 33,005 33,005 26,546
Amortization 4,681 4,681 4,309
Restructuring benefit (860) 860 (b) -
'/>"/>
| SOURCE PAREXEL International Corporation Copyright©2008 PR Newswire. All rights reserved |